New Journal to Offer Rapid Publication of Specialized Interest Research

LONDON – June 8, 2010 — Informa Healthcare announced today that it will be launching its first open-access journal, the Journal of Drug Assessment (JDA). The online, peer-reviewed journal will focus on the rapid publication of specialized interest research, including inconclusive and negative clinical trial results. The journal will be launched this autumn.

“Regulatory requirements are changing, and pharmaceutical companies are facing pressure to publish all clinical trial data. Traditionally, journals have focused on the publication of conclusive trial results,” explained Publisher Jay Magrann. “This journal’s mission is to channel the specialized interest research that may otherwise be excluded by many journals’ selection policies to physicians and the public alike.”

 JDA will be part of a new journal series with Current Medical Research & Opinion (CMRO) and the Journal of Medical Economics (JME). Like its sister titles, JDA will offer rapid and rigorously peer-reviewed publication of clinical trial data.

JDA will join Informa Healthcare’s portfolio of over 170 journals, including CMRO, the Expert Opinion series, the Critical Review series, Leukemia and Lymphoma, Clinical Toxicology, and society journals including Harvard Review of Psychiatry, Acta Oncologica and British Journal of Neurosurgery.

More information and updates are available on informahealthcare.com/jda.

About Informa Healthcare

Informa Healthcare provides authoritative research and analysis for all sectors of the Life Science, Medicine and Pharmaceutical sectors to better serve the commercial and academic needs within the scientific and clinical communities. Informa Healthcare is a division of Informa plc (London: INF).

Informa has more than 150 offices in 40 countries and employs 7,500 staff around the world. Informa Healthcare is headquartered in London with offices in New York, Melbourne, Singapore and Stockholm. For more information, visit: http://www.informahealthcare.com

About Current Medical Research & Opinion

CMRO is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations. Its mission is to provide ethical, unbiased and rapid publication of quality content that is validated by rigorous peer review and serves the information needs of the clinical medicine community. As a member of the Committee on Publication Ethics (COPE), the journal takes an active role in supporting Good Publication Practice and advancing transparency in publication.

For more information, visit: http://www.cmrojournal.com/

 About Journal of Medical Economics

JME is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication of high-quality economic assessments of novel therapeutic and device interventions. Its mission is to provide ethical, unbiased and rapid publication of quality content that is validated by rigorous peer review and to serve the information needs of the pharmacoeconomics and healthcare research community. As a member of the Committee on Publication Ethics (COPE), the journal takes an active role in supporting Good Publication Practice and advancing transparency in publication.

For more information, visit: http://informahealthcare.com/loi/jme.